Roth, N.; Schön, J.; Hoffmann, D.; Thran, M.; Thess, A.; Mueller, S.O.; Petsch, B.; Rauch, S.
Optimised Non-Coding Regions of mRNA SARS-CoV-2 Vaccine CV2CoV Improves Homologous and Heterologous Neutralising Antibody Responses. Vaccines 2022, 10, 1251.
https://doi.org/10.3390/vaccines10081251
AMA Style
Roth N, Schön J, Hoffmann D, Thran M, Thess A, Mueller SO, Petsch B, Rauch S.
Optimised Non-Coding Regions of mRNA SARS-CoV-2 Vaccine CV2CoV Improves Homologous and Heterologous Neutralising Antibody Responses. Vaccines. 2022; 10(8):1251.
https://doi.org/10.3390/vaccines10081251
Chicago/Turabian Style
Roth, Nicole, Jacob Schön, Donata Hoffmann, Moritz Thran, Andreas Thess, Stefan O. Mueller, Benjamin Petsch, and Susanne Rauch.
2022. "Optimised Non-Coding Regions of mRNA SARS-CoV-2 Vaccine CV2CoV Improves Homologous and Heterologous Neutralising Antibody Responses" Vaccines 10, no. 8: 1251.
https://doi.org/10.3390/vaccines10081251
APA Style
Roth, N., Schön, J., Hoffmann, D., Thran, M., Thess, A., Mueller, S. O., Petsch, B., & Rauch, S.
(2022). Optimised Non-Coding Regions of mRNA SARS-CoV-2 Vaccine CV2CoV Improves Homologous and Heterologous Neutralising Antibody Responses. Vaccines, 10(8), 1251.
https://doi.org/10.3390/vaccines10081251
